Key result
Maternal SARS-CoV-2 infection during pregnancy was associated with elevated cardiac troponin-I levels in asymptomatic neonates compared to a baseline cohort.
Why the study?
Cardiac troponin-I is a known biomarker of myocardial injury in adults and children, but its diagnostic utility in newborns remains unclear.
What are the normative cardiac troponin-I levels in stable newborn infants at 24 hours of age, and do they vary by maternal or delivery factors?
Observational (n=132)
No
What are the normative cardiac troponin-I levels in stable newborn infants at 24 hours of age, and do they vary by maternal or delivery factors?
Normative cardiac troponin-I levels in healthy term newborns at 24 hours of age are comparable to healthy children and adults, but are elevated in asymptomatic neonates born to mothers with SARS-CoV-2 during pregnancy.
Answers are grounded in this paper and cite their sources.
Provides normative troponin-I values for stable newborns; leaves open diagnostic thresholds for myocardial injury in this population.
Cardiac troponin-I is a known biomarker of myocardial injury in adults and children but its diagnostic utility is unclear in newborns. This study aimed to establish normative data for troponin-I in stable newborns and assess any variation due to maternal diabetes status, mode of delivery, and Apgar scores. Prospective, observational study of stable newborn ≥35 weeks gestation admitted to a well-baby nursery at a single institution. Infants with respiratory distress, congenital infections, malformations, or syndromes were excluded. Troponin-I values were obtained by a validated point-of-care capillary blood sample at 24 hours of age. A total of 132 patients were included for analysis. Thirteen infants were born to mothers with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy and analyzed as a subgroup, with the remaining 119 infants comprising the base cohort to establish baseline normative troponin-I levels in stable newborn infants. The mean (standard deviation) troponin-I level of infants in the base cohort group was 0.019 ± 0.018 ng/mL and in infants born with maternal SARS-CoV-2 infection during pregnancy troponin-I level was 0.081 ± 0.1 ng/mL (p < 0.001). In infants of the base cohort, there was no significant difference in troponin-I levels between diabetic versus nondiabetic mothers, vaginal birth versus cesarean section, and 5-minute Apgar score of <7 versus ≥7. Cardiac troponin-I level in healthy term newborns was 0.019 ± 0.018 ng/mL, which conforms to healthy children and adult lab values. There was no statistically significant difference in troponin-I levels in infants of maternal diabetes or normal glucose status, mode of delivery, cesarean versus vaginal, or 5-minute Apgar score of <7 or ≥7. Troponin-I levels in asymptomatic neonates born to mothers with a history of SARS-CoV-2 during pregnancy demonstrated an elevation when compared to the baseline group of infants.
No takes yet. Share an insight, caveat, or question.
Rosario et al. (2024) conducted an observational in Stable newborn infants (n=132). Maternal SARS-CoV-2 infection during pregnancy vs. Base cohort (no maternal SARS-CoV-2 infection) was evaluated on Cardiac troponin-I level at 24 hours of age (ng/mL) (p=<0.001). Maternal SARS-CoV-2 infection during pregnancy was associated with elevated cardiac troponin-I levels in asymptomatic neonates compared to a baseline cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: